|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.190 USD | +1.39% |
|
+6.31% | -59.22% |
| 06-29 | Compass Therapeutics, Inc.(NasdaqCM:CMPX) dropped from Russell 3000E Growth Benchmark | CI |
| 06-28 | Compass Therapeutics, Inc.(NasdaqCM:CMPX) dropped from Russell 3000 Growth Benchmark | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 389M | - | - | - | - | - |
| 55.78B | |||||
| 55.66B | |||||
| 23.84B | - | ||||
| 22.7B | - | ||||
| 18.5B |
Select your edition
All financial news and data tailored to specific country editions
